Form 8-K - Current report:
SEC Accession No. 0001493152-25-008281
Filing Date
2025-02-26
Accepted
2025-02-26 08:30:53
Documents
29
Period of Report
2025-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38083
2 ex99-1.htm EX-99.1 15129
3 ex99-1_001.jpg GRAPHIC 1766445
4 ex99-1_002.jpg GRAPHIC 2813837
5 ex99-1_003.jpg GRAPHIC 2121161
6 ex99-1_004.jpg GRAPHIC 1811817
7 ex99-1_005.jpg GRAPHIC 2075057
8 ex99-1_006.jpg GRAPHIC 2117503
9 ex99-1_007.jpg GRAPHIC 1665753
10 ex99-1_008.jpg GRAPHIC 1320933
11 ex99-1_009.jpg GRAPHIC 1543928
12 ex99-1_010.jpg GRAPHIC 1539940
13 ex99-1_011.jpg GRAPHIC 2325591
14 ex99-1_012.jpg GRAPHIC 1849481
15 ex99-1_013.jpg GRAPHIC 1758700
16 ex99-1_014.jpg GRAPHIC 2121531
17 ex99-1_015.jpg GRAPHIC 1065998
  Complete submission text file 0001493152-25-008281.txt   38594238

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE envb-20250226.xsd EX-101.SCH 3012
19 XBRL LABEL FILE envb-20250226_lab.xml EX-101.LAB 34240
20 XBRL PRESENTATION FILE envb-20250226_pre.xml EX-101.PRE 22357
31 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25666283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)